New clinical trials regulation targeted for early phase trials

In this SPARK Europe Webinar, Lenka Součková & Radka Obermannová will present their experiences with the changes, that the New Clinical Trials Regulation has brought and which of them are related to the early-phase trails.


MS Teams

SPARK Europe Webinar Series | 7th June 2023 | 4-5 pm (CET) | New clinical trials regulation targeted for early phase trials | Lenka Součková & Radka Obermannová

The new Clinical Trials Regulation was implemented on January 31st 2023. The first experience will be presented. What are the pitfalls of transferring research to the clinical evaluation phase? 

Lenka is a European Correspondent for the Czech Republic of ECRIN (European Clinical Research Infrastructure Network). She also represents CZECRIN National Network and is a researcher at the Department of Pharmacology, Faculty of Medicine, Masaryk University.
Radka is a clinical oncologist at the Department of Complex Oncological Care at the Faculty of Medicine, Masaryk University, and Masaryk Memorial Cancer Institute in Brno, CZ. She is the head of the Early Phase Trials Unit, and the principal investigator in many clinical trials.

Online via MS Teams ǀ Please register here.

Registration for the webinar is required in advance. The webinar will be hosted by SPARK at the Faculty of Medicine, Masaryk University, Brno, Czech Republic.

SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Denmark and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.

SPARK-BIH is a member of the SPARK Global network